{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:54:23Z","timestamp":1783605263499,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["PC1-08103"],"award-info":[{"award-number":["PC1-08103"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shriners Hospital for Children research","award":["8512"],"award-info":[{"award-number":["8512"]}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation Basil O'Connor Starter Scholar Research","doi-asserted-by":"publisher","award":["5FY1682"],"award-info":[{"award-number":["5FY1682"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.placenta.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T15:19:28Z","timestamp":1495120768000},"page":"107-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Potential clinical applications of placental stem cells for use in fetal therapy of birth defects"],"prefix":"10.1016","volume":"59","author":[{"given":"Melissa","family":"Vanover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-3627","authenticated-orcid":false,"given":"Aijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib1","first-page":"1","article-title":"Georgia, 1978-2005, MMWR. Morbidity and mortality weekly report","volume":"57","author":"Update on overall prevalence of major birth defects\u2013Atlanta","year":"2008"},{"issue":"9","key":"10.1016\/j.placenta.2017.05.010_bib2","first-page":"1","article-title":"Infant mortality statistics from the 2013 period linked birth\/infant death data set","volume":"64","author":"Mathews","year":"2015","journal-title":"Natl. Vital Stat. Rep."},{"issue":"2","key":"10.1016\/j.placenta.2017.05.010_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15585\/mmwr.mm6602a1","article-title":"Inpatient hospitalization costs associated with birth defects among persons of all ages - United States, 2013, MMWR","volume":"66","author":"Arth","year":"2017","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.placenta.2017.05.010_bib4","series-title":"Noninvasive Prenatal Diagnosis for Single Gene Disorders, Current Opinion in Obstetrics & Gynecology","author":"Allen","year":"2017"},{"issue":"4","key":"10.1016\/j.placenta.2017.05.010_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/AOG.0000000000000476","article-title":"Fetal surgery: principles, indications, and evidence","volume":"124","author":"Wenstrom","year":"2014","journal-title":"Obstetrics Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2017.05.010_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/NMM:2:3:233","article-title":"Stem cell and precursor cell therapy","volume":"2","author":"Cai","year":"2002","journal-title":"Neuromolecular Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13287-016-0418-9","article-title":"Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta","volume":"7","author":"Du","year":"2016","journal-title":"Stem Cell Res. Ther."},{"issue":"19","key":"10.1016\/j.placenta.2017.05.010_bib8","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1089\/scd.2013.0016","article-title":"Mesenchymal stromal cell characteristics vary depending on their origin","volume":"22","author":"Wegmeyer","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.placenta.2017.05.010_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000354895","article-title":"A\u00a0comparative study on culture conditions and routine expansion of amniotic fluid-derived mesenchymal progenitor cells","volume":"34","author":"Gucciardo","year":"2013","journal-title":"Fetal Diagnosis Ther."},{"issue":"12","key":"10.1016\/j.placenta.2017.05.010_bib10","doi-asserted-by":"crossref","first-page":"e115963","DOI":"10.1371\/journal.pone.0115963","article-title":"Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem\/stromal cells","volume":"9","author":"Beane","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.placenta.2017.05.010_bib11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.17772\/gp\/1673","article-title":"Expression and co-expression of surface markers of pluripotency on human amniotic cells cultured in different growth media","volume":"84","author":"Bryzek","year":"2013","journal-title":"Ginekol. Pol."},{"issue":"5","key":"10.1016\/j.placenta.2017.05.010_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/14712598.2015.1000856","article-title":"How far are we from the clinical use of placental-derived mesenchymal stem cells?","volume":"15","author":"Fierabracci","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.placenta.2017.05.010_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4161\/org.22238","article-title":"Congenital anomalies: treatment options based on amniotic fluid-derived stem cells","volume":"8","author":"Kunisaki","year":"2012","journal-title":"Organogenesis"},{"issue":"DEC","key":"10.1016\/j.placenta.2017.05.010_bib14","article-title":"In utero therapy for congenital disorders using amniotic fluid stem cells","volume":"5","author":"Ramachandra","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.placenta.2017.05.010_bib15","doi-asserted-by":"crossref","unstructured":"N.M. Gude, C.T. Roberts, B. Kalionis, R.G. King, Growth and function of the normal human placenta, Thrombosis Res. 114(5) 397\u2013407..","DOI":"10.1016\/j.thromres.2004.06.038"},{"issue":"2","key":"10.1016\/j.placenta.2017.05.010_bib16","first-page":"64","article-title":"Human term placental cells: phenotype, properties and new avenues in regenerative medicine","volume":"1","author":"Caruso","year":"2012","journal-title":"Int. J. Mol. Cell. Med."},{"issue":"7","key":"10.1016\/j.placenta.2017.05.010_bib17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","article-title":"Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta","volume":"22","author":"In 't Anker","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.placenta.2017.05.010_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.08.014","article-title":"Placental stem cells","volume":"31","author":"Antoniadou","year":"2016","journal-title":"Best Pract. Res. Clin. Obstetrics Gynaecol."},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10616-008-9162-z","article-title":"Placenta-derived stem cells: new hope for cell therapy?","volume":"58","author":"Evangelista","year":"2008","journal-title":"Cytotechnology"},{"issue":"2","key":"10.1016\/j.placenta.2017.05.010_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1634\/stemcells.2007-0594","article-title":"Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on placenta derived stem cells","volume":"26","author":"Parolini","year":"2008","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.placenta.2017.05.010_bib21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1634\/stemcells.2004-0357","article-title":"Stem cell characteristics of amniotic epithelial cells","volume":"23","author":"Miki","year":"2005","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12015-012-9385-4","article-title":"Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta","volume":"9","author":"Abumaree","year":"2013","journal-title":"Stem Cell Rev."},{"issue":"1\u20132","key":"10.1016\/j.placenta.2017.05.010_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/19336918.2016.1142035","article-title":"Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications","volume":"10","author":"Weber","year":"2016","journal-title":"Cell Adhesion Migr."},{"issue":"3","key":"10.1016\/j.placenta.2017.05.010_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cbin.10032","article-title":"Comparison of human first and third trimester placental mesenchymal stem cell","volume":"37","author":"Park","year":"2013","journal-title":"Cell Biol. Int."},{"issue":"5","key":"10.1016\/j.placenta.2017.05.010_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3727\/096368910X536518","article-title":"Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in\u00a0vitro expansion","volume":"20","author":"Poloni","year":"2011","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v7.i1.195","article-title":"Early gestation chorionic villi-derived stromal cells for fetal tissue engineering","volume":"7","author":"Lankford","year":"2015","journal-title":"World J. Stem Cells"},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00441-012-1340-9","article-title":"Human first-trimester chorionic villi have a myogenic potential","volume":"348","author":"Arakawa","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.placenta.2017.05.010_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1900\/RDS.2010.7.168","article-title":"Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes","volume":"7","author":"Kadam","year":"2010","journal-title":"Rev. Diabet. Stud. RDS"},{"issue":"12","key":"10.1016\/j.placenta.2017.05.010_bib29","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.yexcr.2007.04.028","article-title":"'Working' cardiomyocytes exhibiting plateau action potentials from human placenta-derived extraembryonic mesodermal cells","volume":"313","author":"Okamoto","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.placenta.2017.05.010_bib30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/scd.2007.0154","article-title":"Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells","volume":"17","author":"Barlow","year":"2008","journal-title":"Stem Cells Dev."},{"issue":"Suppl 4","key":"10.1016\/j.placenta.2017.05.010_bib31","first-page":"94s","article-title":"Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation","volume":"51","author":"Barcena","year":"2011","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.placenta.2017.05.010_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12015-014-9562-8","article-title":"Human chorionic villous mesenchymal stem cells modify the functions of human dendritic cells, and induce an anti-inflammatory phenotype in CD1+ dendritic cells","volume":"11","author":"Abomaray","year":"2015","journal-title":"Stem Cell Rev."},{"issue":"6","key":"10.1016\/j.placenta.2017.05.010_bib33","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1159\/000366395","article-title":"Delivery of placenta-derived mesenchymal stem cells ameliorates ischemia induced limb injury by immunomodulation","volume":"34","author":"Zhang","year":"2014","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.placenta.2017.05.010_bib34","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/humrep\/den356","article-title":"Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats","volume":"24","author":"Chen","year":"2009","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.placenta.2017.05.010_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/scd.2009.0404","article-title":"Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table","volume":"19","author":"Parolini","year":"2010","journal-title":"Stem Cells Dev."},{"issue":"10","key":"10.1016\/j.placenta.2017.05.010_bib37","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3727\/096368909X12483162196764","article-title":"Amniotic membrane patching promotes ischemic rat heart repair","volume":"18","author":"Cargnoni","year":"2009","journal-title":"Cell Transpl."},{"issue":"4","key":"10.1016\/j.placenta.2017.05.010_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/cell.2012.0002","article-title":"Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects","volume":"14","author":"Li","year":"2012","journal-title":"Cell. Reprogr."},{"issue":"4","key":"10.1016\/j.placenta.2017.05.010_bib39","first-page":"484","article-title":"Transplantation of human amnion mesenchymal cells attenuates the disease development in rats with collagen-induced arthritis","volume":"33","author":"Shu","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.placenta.2017.05.010_bib40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/resp.12343","article-title":"A\u00a0phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Chambers","year":"2014","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.placenta.2017.05.010_bib41","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/jcb.22873","article-title":"Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases","volume":"111","author":"Lee","year":"2010","journal-title":"J.\u00a0Cell Biochem."},{"issue":"6","key":"10.1016\/j.placenta.2017.05.010_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1704811","article-title":"In utero transplantation: baby steps towards an effective therapy","volume":"35","author":"Muench","year":"2005","journal-title":"Bone marrow Transplant."},{"issue":"5","key":"10.1016\/j.placenta.2017.05.010_bib43","first-page":"346","article-title":"Stem cell therapy in utero","volume":"28","author":"Pschera","year":"2000","journal-title":"J.\u00a0Perinat. Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib44","first-page":"189","article-title":"Fetal stem-cell transplantation, Best practice & research","volume":"22","author":"Tiblad","year":"2008","journal-title":"Clin. Obstetrics Gynaecol."},{"issue":"10","key":"10.1016\/j.placenta.2017.05.010_bib45","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/01.TP.0000144606.84234.49","article-title":"Engraftment potential of human amnion and chorion cells derived from term placenta","volume":"78","author":"Bailo","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.placenta.2017.05.010_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10561-013-9402-0","article-title":"Feasibility and potential of in utero foetal membrane-derived cell transplantation","volume":"15","author":"Caruso","year":"2014","journal-title":"Cell Tissue Bank."},{"issue":"12","key":"10.1016\/j.placenta.2017.05.010_bib47","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-11-537571","article-title":"Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation","volume":"124","author":"Vrecenak","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.sempedsurg.2012.10.010","article-title":"Stem cell and genetic therapies for the fetus","volume":"22","author":"Pearson","year":"2013","journal-title":"Seminars Pediatr. Surg."},{"issue":"5","key":"10.1016\/j.placenta.2017.05.010_bib49","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood.V99.5.1870","article-title":"Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000020793","article-title":"Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1","volume":"13","author":"Hayward","year":"1998","journal-title":"Fetal Diagn Ther."},{"issue":"10","key":"10.1016\/j.placenta.2017.05.010_bib51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1055\/s-0033-1363501","article-title":"In utero stem cell transplantation for radical treatment of osteogenesis imperfecta: perspectives and controversies","volume":"31","author":"Amin","year":"2014","journal-title":"Am. J. Perinatol."},{"issue":"2","key":"10.1016\/j.placenta.2017.05.010_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5966\/sctm.2013-0090","article-title":"Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience","volume":"3","author":"Gotherstrom","year":"2014","journal-title":"Stem Cells Transl. Med."},{"issue":"5","key":"10.1016\/j.placenta.2017.05.010_bib53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cbin.10037","article-title":"Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice","volume":"37","author":"Yang","year":"2013","journal-title":"Cell Biol. Int."},{"issue":"11","key":"10.1016\/j.placenta.2017.05.010_bib54","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1014379","article-title":"D.L. Farmer a randomized trial of prenatal versus postnatal repair of myelomeningocele","volume":"364","author":"Adzick","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpedsurg.2013.09.043","article-title":"In utero repair of myelomeningocele with autologous amniotic membrane in the fetal lamb model","volume":"49","author":"Brown","year":"2014","journal-title":"J.\u00a0Pediatr. Surg."},{"issue":"6","key":"10.1016\/j.placenta.2017.05.010_bib56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5966\/sctm.2014-0296","article-title":"Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000350267","article-title":"Intra-amniotic delivery of amniotic-derived neural stem cells in a syngeneic model of spina bifida","volume":"34","author":"Turner","year":"2013","journal-title":"Fetal Diagnosis Ther."},{"issue":"6","key":"10.1016\/j.placenta.2017.05.010_bib58","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jpedsurg.2016.02.071","article-title":"A\u00a0comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida","volume":"51","author":"Feng","year":"2016","journal-title":"J.\u00a0Pediatr. Surg."},{"issue":"3","key":"10.1016\/j.placenta.2017.05.010_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/scd.2013.0132","article-title":"Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta","volume":"23","author":"Jones","year":"2014","journal-title":"Stem Cells Dev."},{"issue":"3","key":"10.1016\/j.placenta.2017.05.010_bib60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.26150","article-title":"Placental stem cell correction of murine intermediate maple syrup urine disease","volume":"57","author":"Skvorak","year":"2013","journal-title":"Hepatol. Baltim. Md.)"},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jss.2014.04.013","article-title":"Paracrine regulation of fetal lung morphogenesis using human placenta-derived mesenchymal stromal cells","volume":"190","author":"Di Bernardo","year":"2014","journal-title":"J.\u00a0Surg. Res."},{"issue":"Suppl 4","key":"10.1016\/j.placenta.2017.05.010_bib62","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1016\/j.placenta.2011.04.001","article-title":"Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth","volume":"32","author":"Weber","year":"2011","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2017.05.010_bib63","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2298\/VSP130410050I","article-title":"Manufacturing and use of human placenta-derived mesenchymal stromal cells for phase I clinical trials: establishment and evaluation of a protocol","volume":"71","author":"Ilic","year":"2014","journal-title":"Vojnosanit. Pregl."},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.14636","article-title":"Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis","volume":"45","author":"Akolekar","year":"2015","journal-title":"Ultrasound Obstetrics Gynecol."},{"key":"10.1016\/j.placenta.2017.05.010_bib65","first-page":"CD003252","article-title":"Amniocentesis and chorionic villus sampling for prenatal diagnosis","volume":"3","author":"Alfirevic","year":"2003","journal-title":"Cochrane database Syst. Rev."},{"key":"10.1016\/j.placenta.2017.05.010_bib66","doi-asserted-by":"crossref","unstructured":"P. DeKoninck, J. Toelen, S. Zia, M. Albersen, R. Lories, P.D. Coppi, J. Deprest, Routine isolation and expansion late mid trimester amniotic fluid derived mesenchymal stem cells in a cohort of fetuses with congenital diaphragmatic hernia, Eur. J. Obstetrics Gynecol. Reproductive Biol. 178 157\u2013162.","DOI":"10.1016\/j.ejogrb.2014.04.007"},{"issue":"Suppl B","key":"10.1016\/j.placenta.2017.05.010_bib67","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S0143-4004(03)00140-1","article-title":"The hopes and fears of in utero gene therapy for genetic disease\u2013a review","volume":"24","author":"Coutelle","year":"2003","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2017.05.010_bib68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/stem.1839","article-title":"Sheep CD34+ amniotic fluid cells have hematopoietic potential and engraft after autologous in utero transplantation","volume":"33","author":"Shaw","year":"2015","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.placenta.2017.05.010_bib69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/clo.2009.0046","article-title":"Identification of multipotent cytotrophoblast cells from human first trimester chorionic villi","volume":"11","author":"Spitalieri","year":"2009","journal-title":"Cloning stem cells"},{"issue":"6","key":"10.1016\/j.placenta.2017.05.010_bib70","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bpobgyn.2004.07.001","article-title":"Amniotic fluid and placental stem cells","volume":"18","author":"Fauza","year":"2004","journal-title":"Best Pract. Res. Clin. Obstetrics Gynaecol."},{"issue":"3","key":"10.1016\/j.placenta.2017.05.010_bib71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/cell.2011.0106","article-title":"Human amniotic epithelial cells are reprogrammed more efficiently by induced pluripotency than adult fibroblasts","volume":"14","author":"Easley","year":"2012","journal-title":"Cell. Reprogr."},{"issue":"9","key":"10.1016\/j.placenta.2017.05.010_bib72","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/ten.tec.2013.0480","article-title":"Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications","volume":"20","author":"Jiang","year":"2014","journal-title":"Tissue Eng. - Part C. Methods"},{"issue":"5","key":"10.1016\/j.placenta.2017.05.010_bib73","first-page":"467","article-title":"Report of the international regulatory forum on human cell therapy and gene therapy products","volume":"44","author":"Hayakawa","year":"2016","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"issue":"5","key":"10.1016\/j.placenta.2017.05.010_bib74","doi-asserted-by":"crossref","first-page":"448","DOI":"10.5966\/sctm.2014-0253","article-title":"Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis","volume":"4","author":"Danieli","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"7","key":"10.1016\/j.placenta.2017.05.010_bib75","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jcb.25459","article-title":"Placenta mesenchymal stem cell derived exosomes confer plasticity on fibroblasts","volume":"117","author":"Tooi","year":"2016","journal-title":"J.\u00a0Cell Biochem."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340041730276X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340041730276X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:56:09Z","timestamp":1758909369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014340041730276X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":75,"alternative-id":["S014340041730276X"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2017.05.010","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential clinical applications of placental stem cells for use in fetal therapy of birth defects","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}